Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Simmons

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|August 11, 2010
Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibilityWilliam J Simmons
Nature Biotechnology|May 4, 2004
Effecting a comprehensive intellectual property strategy using the Madrid ProtocolWilliam J Simmons
Nature Biotechnology|July 11, 2013
Bowman v. Monsanto and the protection of patented replicative biologic technologiesWilliam J Simmons
Nature Biotechnology|March 10, 2009
Bilski blundering biotechWilliam J Simmons
Leukemia Research|May 15, 2002
Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J miceJanine Wajchman, William J Simmons, Andrew Klein, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of mammary tumor virus superantigenRajan M Thomas, Kamran Haleem, Abu B Siddique, et al.
Nature Medicine|May 17, 2005
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic targetRoberto Chiarle, William J Simmons, Honjying Cai, et al.
Blood|November 9, 2002
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsRoberto Chiarle, Jerald Z Gong, Ilaria Guasparri, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2014
Identification of novel nuclear targets of human thioredoxin 1Changgong Wu, Mohit Raja Jain, Qing Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|August 11, 2010
Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibilityWilliam J Simmons
Nature Biotechnology|May 4, 2004
Effecting a comprehensive intellectual property strategy using the Madrid ProtocolWilliam J Simmons
Nature Biotechnology|July 11, 2013
Bowman v. Monsanto and the protection of patented replicative biologic technologiesWilliam J Simmons
Nature Biotechnology|March 10, 2009
Bilski blundering biotechWilliam J Simmons
Leukemia Research|May 15, 2002
Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J miceJanine Wajchman, William J Simmons, Andrew Klein, et al.
Cell Cycle (Georgetown, Tex.)|August 6, 2005
New and old functions of STAT3: a pivotal target for individualized treatment of cancerGiorgio Inghirami, Roberto Chiarle, William J Simmons, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of mammary tumor virus superantigenRajan M Thomas, Kamran Haleem, Abu B Siddique, et al.
Nature Medicine|May 17, 2005
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic targetRoberto Chiarle, William J Simmons, Honjying Cai, et al.
Blood|November 9, 2002
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsRoberto Chiarle, Jerald Z Gong, Ilaria Guasparri, et al.
Molecular & Cellular Proteomics : MCP|September 19, 2014
Identification of novel nuclear targets of human thioredoxin 1Changgong Wu, Mohit Raja Jain, Qing Li, et al.
Pageof 2